The importance of metagenomics research in human ecological niches and their role in the diagnosis of noninfectious diseases

• Autorzy: Weiner M. , Kubajka M.
• Języki publikacji: EN

Abstrakty

EN

Human body is a complex system that is affected by a significant number of microscopic organisms called the microbiomes. The dynamic development of science has led to innovative discoveries in the field of microbiology. This in turn has extracted new field, metagenomics, thanks to which it became possible to perform detailed analysis of individual groups of bacteria and to determine their effects on preserving a good health. One of the biggest scientific projects that would investigate the influence of microbiomes on humans is HMP (Human Microbiome Project). As part of it the research is being conducted leading to characterize human microbiome at the level of nucleotide sequence of the entire genomic DNA. The microflora of the skin, oral cavity, respiratory tract, digestive tract (intestines), genitourinary system has an essential role in the homeostasis. In the last year the carried research proved that it is a vital part of the human organism in preserving a good health. Any changes in its composition may lead to systemic diseases. Pathological changes affect the outcome of the interaction within the microflora that includes species of commensal and pathogenic bacteria, as well as immunology and genetics of the host. Metagenomics research will contribute not only to the recognition of new, so far unidentified by the bacteriological methods microorganisms, but most of all they will serve as a basis to understand the relationships between the human organism and in-dwelling microorganisms. Thanks to the development of the metagenomics or the NGS (Next Generation Sequencing) it will be possible to discover new metabolic pathways and bidirectional links of bacteria with human metabolism. This will help in finding new therapeutic methods in the treatment of many noninfectious diseases so far considered as civilization diseases or genetically conditioned.

Słowa kluczowe

EN

metagenomics; human disease; diagnosis; non-infectious disease; Human Microbiome project; next generation sequencing; DNA sequencing

• Wydawca: -
• Czasopismo: Health Problems of Civilization
• Rocznik: 2015
• Tom: 09
• Numer: 2
• Opis fizyczny: p.43-49,fig.,ref.

Twórcy

autor

Weiner M.

• Pope John Paul II State School of Higher Education in Biala Podlaska, Sidorska 95/97, 21-500 Biala Podlaska, Poland

autor

Kubajka M.

• National Veterinary Research Institute in Pulawy, Pulawy, Poland

Bibliografia

• 1. Biesecker L.G. (2012), Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project. Genet. Med., 4, 393–398.
• 2. Binek M. (2012), Mikrobiom człowieka – zdrowie i choroba. Post. Mikrobiol., 51, 27–36.
• 3. Chan E.Y. (2005), Advances in sequencing technology. Mutation Resarch, 573,13–40.
• 4. Fiedurek J. (2014), Mikrobiom a zdrowie człowieka. Wydawnictwo UMCS Lublin.
• 5. Franczuk A., Jagusztyn–Krynicka E.K. (2012), Rola mikroflory jelit w indukcji choroby Leśniewskiego – Crohna w świetle programu badań Human Microbiome Project. Post. Mikrobiol. 51, 257 – 264.
• 6. Furet J.P., Kong L.C., Tap J., Poitou C., Basdevant A., Bouillot J.L., Mariat D., Corthier G., Doré J., Henegar C., Rizkalla S., Clément K. (2010), Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes, 59, 3049-3057.
• 7. Gill S.R., Pop M., DeBoy R.T. (2006), Metagenomic analysis of the human distal gut microbiome. Science, 312, 1355-1359.
• 8. Górecka D., Puścińska E. (2014), Mikrobiom układu oddechowego. Pneumopnol. Alergol. Pol., 82, 481–485.
• 9. Griece E.A., Segre J.A. (2011), The skin microbiome. Nat. Rev. Microbiol. 9, 244-253.
• 10. Handelsman J., Rondon M.R., Brady S.F., Clardy J., Goodman R.M. (1998), Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem. Biol. 5, 245–249.
• 11. Handelsman J. (2004), Metagenomics Application of genomics to uncultured microorganismas. Microbiol. Mol. Biol. Rev. 68, 669-685.
• 12. Hattori M., Taylor T.D. (2009), The human intestinal microbiome: a new frontier of human biology. DNA Research 16, 1-12.
• 13. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. (2006), Microbial ecology: Human gut microbes associated with obesity. Nature, 444, 1022-1023.
• 14. Mira A., Martin-Cuadrado A.B., D’Auria G., Rodriguez-Valera F. (2010), The bacterial pangenome: a new paradigm in microbiology. Int. Microbiol. 13, 45-57.
• 15. Olszewska J., Jagusztyn–Krynicka E.K. (2012), Human Microbiome Project – Mikroflora jelit oraz jej wpływ na fizjologię i zdrowie człowieka. Post. Mikrobiol. 51, 243–256.
• 16. Pallen M.J., Loman N.J., Penn Ch.W. (2010), High-throughput sequencing and clinical microbiology: progress, opportunities and challenges. Curr. Opin. Microbiol. 13, 625-631.
• 17. Pasteur L. (1885), Observations relatives à la note précédente de M. Duclaux. CR Acad. Sci. 100, s.68.
• 18. Peterson J., Guyer M.(2009), The NIH Human Microbiome Project. Genome Res. 19, 2317–2323.
• 19. Reiff C., Kelly D. (2010), Inflammatory bowel disease, gut bacteria and probiotic therapy. Int. J. Med. Microbiol. 300, 25-33.
• 20. Różalska B., Micota B., Budzyńska A., Sadowska B. (2013), Biofilmowy mikrobom skóry w zdrowiu i chorobie. Aspekty badawcze z zakresu inżynierii tkankowej. Forum Zakażeń, 4, 105-110.
• 21. Stachowicz N., Kiersztan A. (2013), Rola mikroflory jelitowej w patogenezie otyłości i cukrzycy. Postępy Hig. Med. Wet. 67, 288-303.
• 22. Stahl D.A., Lane D.J., Olsen G.J., Pace N.R. (1985), Characterization of a Yellowstone hot spring microbial community by 5S rRNA sequences. Appl. Environ. Microbiol., 49, 1379-1384.
• 23. Turnbaugh P.J., Ley R.E., Hamady M. (2007), The human microbiome project. Nature, 449, 804-810.
• 24. Woese C.R. (1987), Bacterial evolution. Microbiol. Rev., 51, 221-271.